U.S. Air Force, Bain Capital, SpaceX, Lockheed Martin
Founders
Scott Dixon, Davide Zanchi
Company Description
Prothegen is developing therapeutics to inhibit or promote ferroptosis, a new type of cell death involved in major life-threatening diseases. Ferroptosis is an iron-mediated failure of antioxidant defenses. Now, Prothegen is developing drugs that stop cells from dying of ferroptosis.